Skip Navigation
About Us > News & Media > News Releases > 1999

Wake Forest Researcher Reports Cholesterol-Lowering Drug Reduces Strokes

A drug already being used to lower cholesterol and prevent heart attacks sharply reduced strokes in patients who already had heart disease, a Wake Forest University researcher told the American Heart Association meeting today (Nov. 8) in Atlanta.

Robert P. Byington, Ph.D., professor and head of the Section on Epidemiology, said the drug, pravastatin, reduced stroke by 20 percent, compared to placebo, in patients with heart disease or high cholesterol.

The study "offers a major new way to lower the stroke rate," Byington said.

He said the drug reduced the risk of stroke over a wide range of cholesterol values and among a wide spectrum of patients in pooled data from three similar clinical trials. The effect occurred primarily in the patients who already had coronary heart disease, where the reduction was 22 percent.

The Prospective Pravastatin Pooling Project began in 1992, before any of the three clinical trials were completed. The three trials - WOS (West of Scotland coronary prevention study), CARE (Cholesterol And Recurrent Events) and LIPID (Long-term Intervention with Pravastatin in Ischemic Disease) totaled 19,768 participants from Scotland, the United States, Canada and Australia-New Zealand.

All were randomized clinical trials that compared 40 milligrams per day of pravastatin to an inert placebo. WOS was conducted in patients with very high cholesterol levels, while CARE and LIPID involved coronary heart disease patients. The data was collected as the studies were underway, with patients remaining in the study an average of five years.

Over the course of the three studies, a total of 267 patients on pravastatin had strokes, compared to 331 patients on the placebo, a statistically significant difference. The stroke rate declined from 6.5 per thousand per year in the placebo group to 5.2 per thousand in the pravastatin group. Most of the strokes were non-fatal; the number of fatal strokes was just about the same in both groups.

The drug prevented the type of stroke caused by the blocking of an artery in the brain, a situation similar to the blocking of a coronary artery in the heart (which leads directly to a heart attack.)

He noted that the effect on stroke was somewhat unexpected. "People have been combining the results from lipid [cholesterol] lowering trials for years and even as late as 1992, in one of the last analyses, there was zero difference in strokes between the groups that were on lipid-lowering drugs and the people who were on placebo."

These earlier studies were done with other kinds of drugs that lower cholesterol. When the class of drugs called statins became available in the late 1980s, "we began seeing a much larger reduction in lipid levels, and amazingly, hints of reduction in stroke - and we weren''t expecting to see that at all."

The new study is strong evidence that pravastatin reduces strokes.

About 600,000 people suffer a non-fatal strokes each year in the United States, and these strokes are a leading cause of serious long-term disability and extensive and expensive rehabilitation.

The Prospective Pravastatin Pooling Project was funded by Bristol Myers Squibb, as were WOS, CARE and LIPID.


Media Contact: Robert Conn, Jim Steele or Mark Wright at (336) 716-4587

Media Relations Contacts:

Quick Reference

News Media Resources

Media Inquiries
Patient Information
Satellite Interviews

Ways to Give
Last Updated: 07-10-2009
Wake Forest Baptist Ranked among Nation’s ‘Best Hospitals’  25 Years in a Row by U.S. News & World ReportComprehensive Cancer Centers National Designation is Renewed2017-2018 Best DoctorsNursing Magnet StatusJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.

© Wake Forest Baptist Medical Center, Medical Center Boulevard, Winston-Salem, NC 27157. All Rights Reserved.